Arcadia Biosciences (RKDA) Other Accumulated Expenses (2014 - 2026)

Arcadia Biosciences (RKDA) has 12 years of Other Accumulated Expenses data on file, last reported at $270000.0 in Q3 2025.

• Quarterly Other Accumulated Expenses rose 800.0% year-over-year to $270000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $270000.0 (up 800.0% YoY) and the FY2024 annual result came in at $172000.0, up 290.91% from the prior year.
• Other Accumulated Expenses held at $270000.0 in Q3 2025, from $270000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $298000.0 in Q4 2022 to a low of $30000.0 in Q3 2024.
• A 5-year average of $206736.8 and a median of $264000.0 in 2021 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses plunged 87.87% — and 2025, when it surged 800.0%.
• Tracing RKDA's Other Accumulated Expenses over 5 years: stood at $264000.0 in 2021, then gained by 12.88% to $298000.0 in 2022, then sank by 85.23% to $44000.0 in 2023, then surged by 290.91% to $172000.0 in 2024, then surged by 56.98% to $270000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $270000.0 (Q3 2025), $270000.0 (Q2 2025), and $270000.0 (Q1 2025), per Business Quant data.